Barnhorst A., Bourgeois J.A., & Macmillan J. (2008). Development of a hospice formulary for psychotropic medications. Palliative & Supportive Care, 6, 71–77.
Bottomley D.M. & Hanks G.W. (1990). Subcutaneous midazolam infusion in palliative care. Journal of Pain and Symptom Management, 5, 259–261.
Breitbart W. (2002). Spirituality and meaning in supportive care: Spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Supportive Care in Cancer 10, 272–280.
Breitbart W. & Cohen K. (2000). Delirium in the terminally ill. In Handbook of psychiatry in palliative medicine, Chochinov H.M. & Breitbart W. (eds.). New York: Oxford University Press, 75–90.
Breitbart W., Gibson C., Poppito S.R., & Berg A. (2004). Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Canadian Journal of Psychiatry, 49, 366–372.
Breitbart W., Marotta R., Platt M.M., et al. (1996). A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry, 153, 231–237.
Chochinov H.M., Hack T., Hassard T., et al. (2005). Dignity therapy: A novel psychotherapeutic intervention for patients near the end of life. Journal of Clinical Oncology, 23, 5520–5525.
Classen C., Butler L.D., Koopman C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494–501.
Emanuel E.J., Ferris F.D., von Gunten C.F., et al. (2005). Education in Palliative and End-of-Life Care for Oncology. Chicago: The EPEC Project.
Ferris F.D. (2004). Last hours of living. Clinics in Geriatric Medicine, 20, 641–667.
Goodwin P.J., Leszcz M., Ennis M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.
Greenstein M. & Breitbart W. (2000). Cancer and the experience of meaning: A group psychotherapy program for people with cancer. American Journal of Psychotherapy, 54, 486–500.
Han C.S. & Kim Y.K. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45, 297–301.
Hirst A. & Sloan R. (2002). Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews, CD003346.
Homsi J., Walsh D., Nelson K.A., et al. (2000). Methylphenidate for depression in hospice practice: A case series. American Journal of Hospice & Palliative Care, 17, 393–398.
Inouye S.K., Zhang Y., Han L., et al. (2006). Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. Journal of General Internal Medicine 21, 1276–1281.
Irwin S.A. & Ferris F.D. (2008). The opportunity for psychiatry in palliative care. Canadian Journal of Psychiatry, 53, 713–724.
Levenson J.L. (2005). The American Psychiatric Publishing textbook of psychosomatic medicine (1st ed.).Washington, DC: American Psychiatric Publishing.
Martinon-Torres G., Fioravanti M., & Grimley E.J. (2004). Trazodone for agitation in dementia. Cochrane Database of Systematic Reviews, CD004990.
Medicare and Medicaid Programs: Hospice Conditions of Participation; Final Rule, 42 C.F.R. Part 418 (2008).
Menza M.A., Kaufman K.R., & Castellanos A. (2000). Modafinil augmentation of antidepressant treatment in depression. Journal of Clinical Psychiatry, 61, 378–381.
Morita T., Tei Y., & Inoue S. (2003). Agitated terminal delirium and association with partial opioid substitution and hydration. Journal of Palliative Medicine, 6, 557–563.
Payne D.K. & Massie M.J. (2000). Anxiety in palliative care. In Handbook of psychiatry in palliative medicine, Chochinov H.M. & Breitbart W. (eds.). New York: Oxford University Press.
Rousseau P. (2004). Palliative sedation in the management of refractory symptoms. Journal of Supportive Oncology, 2, 181–186.
Rousseau P. (2005). Palliative sedation in the control of refractory symptoms. Journal of Palliative Medicine, 8, 10–12.
Rozans M., Dreisbach A., Lertora J.J., et al. (2002). Palliative uses of methylphenidate in patients with cancer: A review. Journal of Clinical Oncology, 20, 335–339.
Rundell J.R., Wise M.G., & Press A.P. (1999). Essentials of consultation-liaison psychiatry: Based on the American Psychiatric Press textbook of consultation-liaison psychiatry (1st ed.).Washington, DC: American Psychiatric Press.
Schatzberg A.F., Cole J.O., & DeBattista C. (2003). Manual of clinical psychopharmacology (4th ed.).Washington, DC: American Psychiatric Publishing.
Schneider L.S., Tariot P.N., Dagerman K.S., et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
Simon G.E., Psaty B.M., Hrachovec J.B., et al. (2005). Principles for evidence-based drug formulary policy. Journal of General Internal Medicine, 20, 964–968.
Sipahimalani A. & Masand P.S. (1998). Olanzapine in the treatment of delirium. Psychosomatics, 39, 422–430.
Skrobik Y.K., Bergeron N., Dumont M., et al. (2004). Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Medicine, 30, 444–449.
Sood A., Barton D.L., & Loprinzi C.L. (2006). Use of methylphenidate in patients with cancer. American Journal of Hospice & Palliative Care, 23, 35–40.
Spiegel D., Bloom J.R., & Yalom I. (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.
Stahl S.M. (1998). Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. Journal of Clinical Psychiatry, 59 (Suppl 4), 5–14.
Standish L.J., Kozak L., & Congdon S. (2008). Acupuncture is underutilized in hospice and palliative medicine. American Journal of Hospice & Palliative Care, 25, 298–308.
Stiefel F., Fainsinger R., & Bruera E. (1992). Acute confusional states in patients with advanced cancer. Journal of Pain and Symptom Management, 7, 94–98.
Thase M.E., Friedman E.S., Biggs M.M., et al. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. American Journal of Psychiatry, 164, 739–752.
Trivedi M.H., Rush A.J., Wisniewski S.R., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40.